Last update 11 Nov 2024

KH-801

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
KH801
Target
CD24
Mechanism
CD24 inhibitors(CD24 molecule inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Beijing Kanghong Biological Medicine Co., Ltd.
Active Organization
Beijing Kanghong Biological Medicine Co., Ltd.
Inactive Organization
Chengdu Kanghong Pharmaceutical Group Co., Ltd.Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with KH-801
NCT06364501 / Not yet recruitingPhase 1
A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Anti-tumor Activity of KH801 Injection in Patients With Advanced Solid Tumors
CTR20241175 / RecruitingPhase 1
一项评价KH801注射液在晚期实体瘤患者中的安全性、 耐受性、 药代动力学特征和初步抗肿瘤活性的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary anti-tumor activity of KH801 injection in patients with advanced solid tumors
100 Clinical Results associated with KH-801
Login to view more data
100 Translational Medicine associated with KH-801
Login to view more data
100 Patents (Medical) associated with KH-801
Login to view more data
100 Deals associated with KH-801
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
CN
Beijing Kanghong Biological Medicine Co., Ltd.
17 May 2024
NeoplasmsPreclinical
CN
Chengdu Kanghong Pharmaceutical Group Co., Ltd.Chengdu Kanghong Pharmaceutical Group Co., Ltd.
31 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free